Try our Advanced Search for more refined results

Microbiome Biotech Seres Sets Terms For $106M IPO

By Matthew Perlman (June 16, 2015, 2:46 PM EDT) -- Venture capital-backed biotech company Seres Therapeutics Inc., which is developing microbiome therapies to replace beneficial bacteria in the gut, set terms for its initial public offering on Tuesday, looking to raise as much as $106 million as it wades into this year's uncertain IPO market for biotechs....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Related Sections

Law Firms

Companies

Government Agencies

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!